BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30835026)

  • 1. Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps.
    Cock C; Anwar S; Byrne SE; Meng R; Pedersen S; Fraser RJL; Young GP; Symonds EL
    Dig Dis Sci; 2019 Sep; 64(9):2555-2562. PubMed ID: 30835026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
    Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
    Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).
    Heigh RI; Yab TC; Taylor WR; Hussain FT; Smyrk TC; Mahoney DW; Domanico MJ; Berger BM; Lidgard GP; Ahlquist DA
    PLoS One; 2014; 9(1):e85659. PubMed ID: 24465639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity.
    Chang LC; Shun CT; Hsu WF; Tu CH; Tsai PY; Lin BR; Liang JT; Wu MS; Chiu HM
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):872-879.e1. PubMed ID: 27498176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.
    Yuan SY; Wu W; Fu J; Lang YX; Li JC; Guo Y; Wang YN; Qian JM; Li JN
    J Dig Dis; 2019 Feb; 20(2):78-82. PubMed ID: 30714346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
    Kligman E; Li W; Eckert GJ; Kahi C
    Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; de Pretis G; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex DK; Zappa M; Hassan C;
    Gut; 2017 Jul; 66(7):1233-1240. PubMed ID: 26896459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal immunochemical testing results and characteristics of colonic lesions.
    van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
    Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold.
    Young GP; Woodman RJ; Symonds E
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32994195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.
    Symonds EL; Pedersen SK; Baker RT; Murray DH; Gaur S; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Young GP
    Clin Transl Gastroenterol; 2016 Jan; 7(1):e137. PubMed ID: 26765125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
    Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
    Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
    Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
    Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
    [No Abstract]   [Full Text] [Related]  

  • 17. Which Fecal Immunochemical Test Should I Choose?
    Daly JM; Xu Y; Levy BT
    J Prim Care Community Health; 2017 Oct; 8(4):264-277. PubMed ID: 28447866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher risk of advanced histology in adenoma less than 10 mm in fecal immunochemical test screening: Implication for management.
    Hsu WF; Cheng SY; Shun CT; Chang LC; Tu CH; Wang HP; Wu MS; Chiu HM
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1738-1745. PubMed ID: 32187748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens.
    Berry E; Miller S; Koch M; Balasubramanian B; Argenbright K; Gupta S
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):647-653. PubMed ID: 31085338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.